Extension of Time to File SOU

EYSUVIS

Kala Pharmaceuticals, Inc.

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90126591
LAW OFFICE ASSIGNED LAW OFFICE 110
MARK SECTION
MARK http://uspto.report/TM/90126591/mark.png (stylized and/or with design)
STANDARD CHARACTERS NO
USPTO-GENERATED IMAGE NO
OWNER SECTION (current)
NAME Kala Pharmaceuticals, Inc.
MAILING ADDRESS 490 Arsenal Way, Suite 120
CITY Watertown
STATE Massachusetts
ZIP/POSTAL CODE 02472
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
OWNER SECTION (proposed)
NAME Kala Pharmaceuticals, Inc.
MAILING ADDRESS 490 Arsenal Way, Suite 120
CITY Watertown
STATE Massachusetts
ZIP/POSTAL CODE 02472
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME ALEXIS CRAWFORD DOUGLAS
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE CItrademarks@klgates.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) alexis.douglas@klgates.com; raquel.bacchus@klgates.com
CORRESPONDENCE INFORMATION (proposed)
NAME Alexis Crawford Douglas
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE CItrademarks@klgates.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) alexis.douglas@klgates.com; raquel.bacchus@klgates.com
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION pharmaceutical preparations and substances for the treatment of ophthalmological and ocular diseases and disorders; topical ophthalmic pharmaceutical preparations; topical ophthalmic pharmaceutical preparations for the relief of the signs and symptoms of dry eye disease
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 03/23/2021
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /acd/
SIGNATORY'S NAME Alexis Crawford Douglas
SIGNATORY'S POSITION Attorney of record, Illinois Bar Member
DATE SIGNED 09/17/2021
SIGNATORY'S PHONE NUMBER (312) 807-4346
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION
SUBMIT DATE Fri Sep 17 18:52:38 ET 2021
TEAS STAMP USPTO/ESU-XXX.XX.XXX.XXX-
20210917185238000241-9012
6591-78159f432063d84eb851
25cb573ee49f13c0229cd25bb
c77b385f48bf65d717b0-DA-5
2354411-20210917181051106
097



PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: EYSUVIS (stylized and/or with design, see http://uspto.report/TM/90126591/mark.png)
SERIAL NUMBER: 90126591

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Kala Pharmaceuticals, Inc., having an address of
      490 Arsenal Way, Suite 120
      Watertown, Massachusetts 02472
      United States
      Email: XXXX
Proposed: Kala Pharmaceuticals, Inc., having an address of
      490 Arsenal Way, Suite 120
      Watertown, Massachusetts 02472
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 03/23/2021.

For International Class 005:
Current identification: pharmaceutical preparations and substances for the treatment of ophthalmological and ocular diseases and disorders; topical ophthalmic pharmaceutical preparations; topical ophthalmic pharmaceutical preparations for the relief of the signs and symptoms of dry eye disease

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

Correspondence Information (current):
      ALEXIS CRAWFORD DOUGLAS
      PRIMARY EMAIL FOR CORRESPONDENCE: CItrademarks@klgates.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): alexis.douglas@klgates.com; raquel.bacchus@klgates.com

Correspondence Information (proposed):
      Alexis Crawford Douglas
      PRIMARY EMAIL FOR CORRESPONDENCE: CItrademarks@klgates.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): alexis.douglas@klgates.com; raquel.bacchus@klgates.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /acd/      Date Signed: 09/17/2021
Signatory's Name: Alexis Crawford Douglas
Signatory's Position: Attorney of record, Illinois Bar Member
Signatory's Phone: (312) 807-4346
Signature method: Sent to third party for signature

PAYMENT: 90126591
PAYMENT DATE: 09/17/2021

Serial Number: 90126591
Internet Transmission Date: Fri Sep 17 18:52:38 ET 2021
TEAS Stamp: USPTO/ESU-XXX.XX.XXX.XXX-202109171852380
00241-90126591-78159f432063d84eb85125cb5
73ee49f13c0229cd25bbc77b385f48bf65d717b0
-DA-52354411-20210917181051106097




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed